SeAH Besteel Becomes First in Korea to Secure Technologies for Two Core Hydrogen Infrastructure Materials
Key Highlights: SeAH Besteel has proven its comprehensive technological capabilities in the hydrogen sector by securing proprietary manufacturing technologies for two core infrastructure materials. This milestone establishes a robust, independent...
SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate
SK bioscience's first mRNA vaccine candidate is expected to enter clinical trials in Australia in February 2025, with interim results expected by 2026. Joint R&D project between SK and CEPI includes up to USD 40 million in initial funding...